Vignesh K Chandiraseharan Selected Research

diglycidyl- (3- (3,3- bisphosphono- 3- hydroxypropylamino)- 2- hydroxypropyl)urazol

1/2022

Noninvasive Ventilation in the Management of Respiratory Failure Due to COVID-19 Infection: Experience From a Resource-Limited Setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vignesh K Chandiraseharan Research Topics

Disease

1	COVID-19 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022
1	Infections 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022

Drug/Important Bio-Agent (IBA)

1	fibrin fragment D (D-dimer)IBA 01/2022
1	diglycidyl- (3- (3,3- bisphosphono- 3- hydroxypropylamino)- 2- hydroxypropyl)urazolIBA 01/2022

Therapy/Procedure

1	Noninvasive Ventilation 01/2022